BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 10228358)

  • 1. [Systemic mastocytosis. A review of current diagnostic and therapeutic approaches].
    Pari F; Zamagni MD; Carnevali C; Pagani M; Rabbi C; Cantore M; Cavazzini G; Aitini E; Smerieri F
    Recenti Prog Med; 1999 Mar; 90(3):169-72. PubMed ID: 10228358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biology, classification and treatment of human mastocytosis.
    Valent P
    Wien Klin Wochenschr; 1996; 108(13):385-97. PubMed ID: 8766423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mastocytosis, classification, biological diagnosis and therapy].
    Arock M
    Ann Biol Clin (Paris); 2004; 62(6):657-69. PubMed ID: 15563424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms.
    Valent P; Sperr WR; Schwartz LB; Horny HP
    J Allergy Clin Immunol; 2004 Jul; 114(1):3-11; quiz 12. PubMed ID: 15241337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mastocytosis: current concepts in diagnosis and treatment.
    Escribano L; Akin C; Castells M; Orfao A; Metcalfe DD
    Ann Hematol; 2002 Dec; 81(12):677-90. PubMed ID: 12483363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic criteria and classification of mastocytosis: a consensus proposal.
    Valent P; Horny HP; Escribano L; Longley BJ; Li CY; Schwartz LB; Marone G; Nuñez R; Akin C; Sotlar K; Sperr WR; Wolff K; Brunning RD; Parwaresch RM; Austen KF; Lennert K; Metcalfe DD; Vardiman JW; Bennett JM
    Leuk Res; 2001 Jul; 25(7):603-25. PubMed ID: 11377686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mastocytosis: a rare case of anaphylaxis in paediatric age and literature review.
    Silva I; Carvalho S; Pinto PL; Machado S; Rosado Pinto J
    Allergol Immunopathol (Madr); 2008; 36(3):154-63. PubMed ID: 18680704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic mastocytosis: current concepts and treatment advances.
    Tefferi A; Pardanani A
    Curr Hematol Rep; 2004 May; 3(3):197-202. PubMed ID: 15087068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Systemic mastocytosis].
    Fain O; Stirnemann J; Lortholary O
    Rev Prat; 2005 Oct; 55(15):1629-36. PubMed ID: 16334197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mastocytosis.
    Metcalfe DD
    Novartis Found Symp; 2005; 271():232-42; discussion 242-9. PubMed ID: 16605139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mastocytosis].
    Rønnov-Jessen AD; Nielsen PL
    Ugeskr Laeger; 1991 Nov; 153(45):3131-4. PubMed ID: 1957356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic mast cell disease (mastocytosis). General aspects and histopathological diagnosis.
    Horny HP; Ruck P; Kröber S; Kaiserling E
    Histol Histopathol; 1997 Oct; 12(4):1081-9. PubMed ID: 9302569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD25 expression on cutaneous mast cells from adult patients presenting with urticaria pigmentosa is predictive of systemic mastocytosis.
    Hollmann TJ; Brenn T; Hornick JL
    Am J Surg Pathol; 2008 Jan; 32(1):139-45. PubMed ID: 18162781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Guidelines for the diagnosis, treatment and management of mastocytosis].
    De la Hoz B; González de Olano D; Alvarez I; Sánchez L; Núñez R; Sánchez I; Escribano L
    An Sist Sanit Navar; 2008; 31(1):11-32. PubMed ID: 18496577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production.
    Butterfield JH; Weiler CR
    Int Arch Allergy Immunol; 2008; 147(4):338-43. PubMed ID: 18622141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunophenotypic characterization of bone marrow mast cells in mastocytosis and other mast cell disorders.
    Sánchez-Muñoz L; Teodósio C; Morgado JM; Escribano L
    Methods Cell Biol; 2011; 103():333-59. PubMed ID: 21722810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current approaches to the diagnosis and treatment of systemic mastocytosis.
    Bains SN; Hsieh FH
    Ann Allergy Asthma Immunol; 2010 Jan; 104(1):1-10; quiz 10-2, 41. PubMed ID: 20143640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical diagnosis of systemic mast cell disorders.
    Roberts LJ; Oates JA
    J Invest Dermatol; 1991 Mar; 96(3):19S-24S; discussion 24S-25S. PubMed ID: 2002247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aleukemic mast cell leukemia (formerly: "malignant mastocytosis"): an extremely rare form of leukemia. A case report and simultaneously a contribution to revised classification of mastocytosis].
    Horny HP; Krokowski M; Feller AC; Hintze G; Sotlar K; Valent P
    Wien Klin Wochenschr; 2002 Mar; 114(5-6):222-8. PubMed ID: 12238313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.